Report we focused on systematically varying and studying hostdonor variations in fundamental electrical properties (ie, APD and CV), further studies are needed to elucidate the particular roles that hostdonor mismatch in individual ion currents, calcium handling, and cell size and geometry would play in vulnerability to conduction block and arrhythmias.NIHPA Author Manuscript NIHPA Author Manuscript NIHPA Author ManuscriptSupplementary MaterialRefer to Internet version on PubMed Central for supplementary material.AcknowledgmentsThe authors thank Ava Krol for NRVM cell isolation, Mark Juhas and Luke McSpadden for assistance with evaluation computer software, and Dawn Pedrotty for strand photomask design.Circ Arrhythm Electrophysiol. Author manuscript; obtainable in PMC 2014 December 01.Kirkton et al.Page 8 Funding Sources: This function was supported by the National Heart, Lung, and Blood Institute in the NIH beneath Award Numbers R01HL104326 and R21 HL106203. The content is solely the responsibility on the authors and does not necessarily represent the official views on the NIH.NIHPA Author Manuscript NIHPA Author Manuscript NIHPA Author Manuscript
Am J Cardiovasc Drugs (2013) 13:35364 DOI 10.1007/s402560130035ORIGINAL Analysis ARTICLEThe Effectiveness and Safety of Landiolol Hydrochloride, an UltraShortActing b1Blocker, in Postoperative Individuals with Supraventricular Tachyarrhythmias: A Multicenter, Randomized, DoubleBlind, PlaceboControlled StudyNobuyuki Taenaka Shinichi KikawaPublished on the web: two July 2013 The Author(s) 2013.27221-49-4 Chemscene This article is published with open access at Springerlink.4-Bromo-3-ethylbenzonitrile web comAbstract Background Persistent postoperative supraventricular tachyarrhythmias (SVTs) improve cardiac burden and aggravate cardiac hemodynamics.PMID:33692021 For that reason, for patients in unstable conditions after surgery, prompt and sustained control of heart price is crucial. The importance of badrenoceptor antagonists (bblockers) in controlling such postoperative atrial fibrillation or atrial flutter has been established, and also the usefulness of ultrashortacting b1blockers with higher b1 selectivity has been suggested based on their security and efficacy below such circumstances. Objectives Our objectives had been to evaluate the effectiveness and safety of landiolol hydrochloride, an ultrashortacting b1selective blocker, in the therapy of postoperative SVT in patients using a high threat of myocardial ischemia, or in individuals after hugely invasive surgery, in a multicenter, randomized, doubleblind, placebocontrolled, groupcomparative study. Strategies A total of 165 individuals were randomly allocated to three groups and received LM or MH doses of landiolol hydrochloride or placebo. LM group: dose L (1min loading dose at a price of 0.03 mg/kg/min, followed by a 10min infusion at 0.01 mg/kg/min) followed by dose M (1min loading at a price of 0.06 mg/kg/min, followed by a 10mininfusion at 0.02 mg/kg/min); MH group: dose M followed by dose H (1min loading dose at a price of 0.125 mg/kg/ min, followed by a 10min infusion at 0.04 mg/kg/min); placebo (PP) group: dose P (1min loading dose at a price of 0 mg/kg/min, followed by a 10min infusion at 0 mg/kg/ min) followed by one more round of dose P. When the targeted heartrate reduction was not obtained at the finish in the initially 10min infusion, the higher dose was began. The principal endpoint was the percentage of sufferers who met the heartrate reduction criteria (C20 reduction and \100 beats/ min). The security endpoint was the incidence of adverse events in each of t.
